MetaCap

Evommune Statistics

NYSE: EVMNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.04-0.20 (-2.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Evommune by the numbers

Evommune has a market capitalization of $291.1 million based on 41.35M shares outstanding. With trailing EPS of $-3.83, Evommune is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.2% below its 50-day average and 58.3% below its 200-day average.

Average daily trading volume is 841.65K shares, or about $5.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EVMN valuation vs. peer median

EVMN compared with the median of 8 peer companies
MetricEVMNPeer medianDifference
Market cap$291.10M$282.20M+3%
Avg. volume841.65K271.45K+210%

Peer median across 8 companies: BNTC, SPRY, GLSI, FULC, RLMD, GALT, VCRE, AVIR.

Valuation

Market cap
$291.10M
Price / sales (latest FY)
22.39
EPS (TTM)
$-3.83

Price and trading

Previous close
7.24
Open
7.10
Day range
6.96 – 7.24
52-week range
4.94 – 33.20
52-week change
-62.37%
Beta
—
Volume
549.40K

Dividends and events

Annual dividend
None
Next earnings date
Dec 10, 2026

Additional statistics

Market Cap
291.10M
Forward Pe
-2.06
Eps
-3.83
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
33.20
Week52 Low
4.94
Avg Volume
841.65K
Shares Outstanding
41.35M
Ma50
7.13
Ma200
16.87
Earnings Date
Dec 10, 2026
Pct From52w High
-78.80%
Pct From52w Low
42.51%

Related